Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Alternext  >  Biocorp    ALCOR   FR0012788065

BIOCORP (ALCOR)
Mes dernières consult.
Most popular
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Euronext Alternext
10/10/2017 10/11/2017 10/12/2017 10/13/2017 10/16/2017 Date
10.79(c) 10.45(c) 10.65(c) 10.65(c) 10.65(c) Last
8 114 7 910 1 917 1 736 3 155 Volume
+2.76% -3.15% +1.91% 0.00% 0.00% Change
More quotes
Company
BIOCORP Production engages in the pharmaceutical and medical industry.Its products include medical and drug delivering devices which are under the names of Newject and Brandject.The company's business activities are research and development and pharmaceutical packaging.BIOCORP was founded in 2004... 
Sector
Pharmaceuticals
Calendar

- No events available -

More about the company
Latest news on BIOCORP
09/28 BIOCORP : Half-Year Results as of June 30, 2017 in Line with Strategy
09/25BIOCORP SA : half-yearly earnings release
05/29 BIOCORP : Signs an Industrialization Contract with Virbac
04/27 BIOCORP : ’s Value Chain Excellence Strengthened Through the Extension of ..
04/06 ANNUAL RESULTS 2016 : BIOCORP Keeps Its Development and Innovation Momentum, Com..
04/03BIOCORP SA : annual earnings release
02/08 BIOCORP : Eric Dessertenne is Appointed Chief Operating Officer
01/25 BIOCORP : to Present Its Innovations at 20th Pharmapack Exhibition, on 1st-2nd F..
01/10 BIOCORP : 2017 Financial Calendar
01/05 BIOCORP PRODUCTION : Announces Participation at Upcoming Events in January 2017
More news
Sector news : Pharmaceuticals - NEC
10/16DJALLERGAN : Loses Patent Fight in Federal Court
10/16DJDaimler Reshapes Company to Meet Challenges of Changing Industry -- Update
10/16 Miners provide foundation for FTSE while ConvaTec plummets
10/16 ASTRAZENECA : Pharma and medtech industries prepare for hard Brexit
10/16 CONVATEC : slashes revenue growth outlook, shares slump
More sector news : Pharmaceuticals - NEC
Latest Tweets
09/28BIOCORP: Half-Year Results as of June 30, 2017 in Line with Strategy  
05/31BioCorp Signs An Industrialization Contract With  
04/27BioCorp???s Value Chain Excellence Strengthened Through The Extension Of Inte.. 
02/08BIOCORP: Eric Dessertenne is Appointed Chief Operating Officer  
01/29Week-end #Biotech #Medtech : Neovacs, Sensorion, I.Ceram, Biocorp, TXCell, CR..
3
More tweets
Qtime:18
Chart BIOCORP
Duration : Period :
Biocorp Technical Analysis Chart | ALCOR | FR0012788065 | 4-Traders
Technical analysis trends BIOCORP
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Managers
NameTitle
Jacques Gardette Chairman & Chief Executive Officer
Eric Dessertenne Chief Operating Officer
Stéphane Chabanais Chief Financial & Administrative Officer
Alain Marcoz Director-Software Research & Development
Emilie Gardette Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOCORP7.04%42
JOHNSON & JOHNSON18.42%366 178
NOVARTIS13.23%225 160
ROCHE HOLDING LTD.5.20%216 764
PFIZER11.88%216 409
MERCK AND COMPANY7.68%172 887